REPL · Replimune Group, Inc.

$10.51 +0.28 (+2.74%) At close · Jul 20

Market Cap

$882.26M

83.95M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Sushil Patel	CEO	$600,000	—	$1,288,359	$1,345,900	$450,000	$13,402	$3,697,661
Konstantinos Xynos	Chief Medical Officer	$516,500	—	$412,241	$430,688	$253,085	$12,351	$1,624,865
Emily Hill	CFO	$516,500	—	$412,241	$430,688	$235,524	—	$1,594,953

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Emily Hill	CFO	$266,538	—	$1,499,940	$1,520,725	$95,954	—	$3,383,157
Konstantinos Xynos	Chief Medical Officer	$499,200	—	$883,000	$896,678	$157,248	$12,238	$2,448,364
Sushil Patel	CEO	$464,880	—	$706,400	$717,342	$162,708	$11,767	$2,063,097

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Philip Astley-Sparke	CEO	$624,000	—	$1,278,200	$1,295,070	$449,280	—	$3,646,550
Jean Franchi	CFO	$464,500	—	$958,650	$971,303	$213,670	—	$2,608,123
Sushil Patel	CEO	$447,000	—	$958,650	$971,303	$205,620	$12,430	$2,595,003

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Sushil Patel	CEO	$394,167	—	$3,246,238	$3,150,038	$152,650	$9,527	$6,952,619
Philip Astley-Sparke	CEO	$600,000	—	$2,697,406	$2,788,372	$280,500	—	$6,366,277
Robert Coffin	President and Chief Research & Development Officer	$551,500	—	$2,427,397	$2,509,262	$234,388	—	$5,722,547

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Andrea Pirzkall	Chief Medical Officer	$261,399	—	—	$4,379,910	$85,262	—	$4,726,571
Philip Astley-Sparke	CEO	$533,000	—	—	$1,698,067	$226,525	—	$2,457,592
Robert Coffin	President and Chief Research & Development Officer	$533,000	—	—	$1,698,067	$226,525	—	$2,457,592

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Robert Coffin	President and Chief Research & Development Officer	$517,500	—	—	$2,208,351	$208,294	—	$2,934,145
Philip Astley-Sparke	CEO	$437,754	—	—	$1,541,213	$176,196	—	$2,155,164
Jean Franchi	CFO	$132,377	—	—	$1,627,200	$42,625	—	$1,802,202
Howard Kaufman	Former Chief Medical Officer	$315,000	—	—	$810,635	—	$149,025	$1,274,660
Pamela Esposito	Chief Business Officer	$362,500	—	—	$762,802	$102,134	—	$1,227,437

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Robert Coffin	President and Chief Research & Development Officer	$477,991	—	—	$1,548,750	$238,996	—	$2,265,737
Howard Kaufman	Former Chief Medical Officer	$406,000	—	—	$1,327,500	$142,100	—	$1,875,600
Philip Astley-Sparke	CEO	$382,393	—	—	$1,239,000	$191,198	—	$1,812,591

Key facts CIK 1737953 CUSIP 76029N106 13F (30d) 18 filings 18 filers Visit website Investor relations